These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
456 related articles for article (PubMed ID: 19280878)
1. Reversion of P-glycoprotein-mediated multidrug resistance in human leukemic cell line by carnosic acid. Yu XN; Chen XL; Li H; Li XX; Li HQ; Jin WR Chin J Physiol; 2008 Dec; 51(6):348-56. PubMed ID: 19280878 [TBL] [Abstract][Full Text] [Related]
2. [Study on reversing mechanism of multidrug resistance of K562/A02 cell line by carnosic acid]. Yu XN; Li H; Chen XL; Li XX; Wang R; Gao F Zhonghua Xue Ye Xue Za Zhi; 2010 Jun; 31(6):381-4. PubMed ID: 21122352 [TBL] [Abstract][Full Text] [Related]
3. The novel bis-benzylisoquinoline PY35 reverses P-glycoprotein-mediated multidrug resistance. Cao Z; Wright M; Cheng J; Huang X; Liu L; Wu L; Yang P Oncol Rep; 2014 Sep; 32(3):1211-7. PubMed ID: 25017650 [TBL] [Abstract][Full Text] [Related]
4. Targeting P-Glycoprotein: Nelfinavir Reverses Adriamycin Resistance in K562/ADR Cells. Liu W; Meng Q; Sun Y; Wang C; Huo X; Liu Z; Sun P; Sun H; Ma X; Liu K Cell Physiol Biochem; 2018; 51(4):1616-1631. PubMed ID: 30497065 [TBL] [Abstract][Full Text] [Related]
5. Effect of phosphatase and tensin homology deleted on chromosome 10 (PTEN) gene transfection on reversal of multidrug resistance in K562/ADM cells. Cheng Z; Yang N; Liang W; Yan X; Li L; Pan L Leuk Lymphoma; 2012 Jul; 53(7):1383-9. PubMed ID: 22185283 [TBL] [Abstract][Full Text] [Related]
6. Timosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K/Akt signaling pathway. Chen JR; Jia XH; Wang H; Yi YJ; Wang JY; Li YJ Int J Oncol; 2016 May; 48(5):2063-70. PubMed ID: 26984633 [TBL] [Abstract][Full Text] [Related]
7. Reversing Multidrug Resistance in Chemo-resistant Human Lung Adenocarcinoma (A549/DOX) Cells by Algerian Propolis Through Direct Inhibiting the P-gp Efflux-pump, G0/G1 Cell Cycle Arrest and Apoptosis Induction. Kebsa W; Lahouel M; Rouibah H; Zihlif M; Ahram M; Abu-Irmaileh B; Mustafa E; Al-Ameer HJ; Al Shhab M Anticancer Agents Med Chem; 2018; 18(9):1330-1337. PubMed ID: 30088453 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of tensin homolog deleted on chromosome ten (PTEN) by ciglitazone sensitizes doxorubicin-resistance leukemia cancer cells to treatment. Mashayekhi S; Yousefi B; Tohidi E; Darband SG; Mirza-Aghazadeh-Attari M; Sadighparvar S; Kaviani M; Shafiei-Irannejad V; Kafil HS; Karimian A; Jadidi-Niaragh F; Majidinia M J Cell Biochem; 2019 Sep; 120(9):15719-15729. PubMed ID: 31087712 [TBL] [Abstract][Full Text] [Related]
9. [Reversal of multidrug resistance in leukemic cell line K562/AO2 by chlordelazine in vitro]. Chen LJ; Shen SH; Wang HM; Ye X; Jiang SY; Gao F; Li GM Zhonghua Er Ke Za Zhi; 2003 Jul; 41(7):525-7. PubMed ID: 14746680 [TBL] [Abstract][Full Text] [Related]
10. The effect of glucosylceramide synthase on P-glycoprotein function in K562/AO2 leukemia drug-resistance cell line. Zhang YY; Xie KM; Yang GQ; Mu HJ; Yin Y; Zhang B; Xie P Int J Hematol; 2011 Mar; 93(3):361-367. PubMed ID: 21380926 [TBL] [Abstract][Full Text] [Related]
11. Reversal effect of PI3-K inhibitor LY294002 on P-glycoprotein-mediated multidrug resistance of human leukemia cell line K562/DNR and gastric cancer cell line SGC7901/ADR. Zhang Y; Qu XJ; Liu YP; Yang XH; Hou KZ; Teng YE; Zhang JD Ai Zheng; 2009 Feb; 28(2):97-9. PubMed ID: 19550116 [TBL] [Abstract][Full Text] [Related]
12. Glabridin resensitizes p-glycoprotein-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents. Qian J; Xia M; Liu W; Li L; Yang J; Mei Y; Meng Q; Xie Y Eur J Pharmacol; 2019 Jun; 852():231-243. PubMed ID: 30959046 [TBL] [Abstract][Full Text] [Related]
13. A new apoptosis inhibitor, CIAPIN1 (cytokine-induced apoptosis inhibitor 1), mediates multidrug resistance in leukemia cells by regulating MDR-1, Bcl-2, and Bax. Li X; Hong L; Zhao Y; Jin H; Fan R; Du R; Xia L; Luo G; Fan D Biochem Cell Biol; 2007 Dec; 85(6):741-50. PubMed ID: 18059532 [TBL] [Abstract][Full Text] [Related]
14. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery. Gu J; Fang X; Hao J; Sha X Biomaterials; 2015 Mar; 45():99-114. PubMed ID: 25662500 [TBL] [Abstract][Full Text] [Related]
15. Reversal of P-glycoprotein-mediated multidrug resistance in vitro by milbemycin compounds in adriamycin-resistant human breast carcinoma (MCF-7/adr) cells. Xiang W; Gao A; Liang H; Li C; Gao J; Wang Q; Shuang B; Zhang J; Yan Y; Wang X Toxicol In Vitro; 2010 Sep; 24(6):1474-81. PubMed ID: 20656007 [TBL] [Abstract][Full Text] [Related]
17. Modulation of multidrug resistant in cancer cells by EGCG, tannic acid and curcumin. Li H; Krstin S; Wink M Phytomedicine; 2018 Nov; 50():213-222. PubMed ID: 30466981 [TBL] [Abstract][Full Text] [Related]
18. Grape seed proanthocyanidin extract reverses multidrug resistance in HL-60/ADR cells via inhibition of the PI3K/Akt signaling pathway. Lin KN; Jiang YL; Zhang SG; Huang SY; Li H Biomed Pharmacother; 2020 May; 125():109885. PubMed ID: 32007917 [TBL] [Abstract][Full Text] [Related]
19. BI-2865, a pan-KRAS inhibitor, reverses the P-glycoprotein induced multidrug resistance in vitro and in vivo. Yang Q; To KKW; Hu G; Fu K; Yang C; Zhu S; Pan C; Wang F; Luo K; Fu L Cell Commun Signal; 2024 Jun; 22(1):325. PubMed ID: 38872211 [TBL] [Abstract][Full Text] [Related]
20. Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes. To KKW; Wu X; Yin C; Chai S; Yao S; Kadioglu O; Efferth T; Ye Y; Lin G J Ethnopharmacol; 2017 May; 203():110-119. PubMed ID: 28363522 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]